Marian A. Castro

Santiago De Compostela, GA 15706, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

SERAAK2 as a Serotonin Receptor Ligand: Structural and Pharmacological In Vitro and In Vivo Evaluation.

SERAAK2 as a Serotonin Receptor Ligand: Structural and Pharmacological In Vitro and In Vivo Evaluation.

Journal: Molecules (Basel, Switzerland)

Published: October 13, 2025

Study protocol for a multimethod investigation of the development of social and nonsocial reward responsivity and depression in autistic adolescents: Reward and Depression in Autism (RDA).

Study protocol for a multimethod investigation of the development of social and nonsocial reward responsivity and depression in autistic adolescents: Reward and Depression in Autism (RDA).

Journal: BMC psychology

Published: May 06, 2025

Synthesis, Experimental and Computational Evaluation of SERAAK1 as a 5-HT2A Receptor Ligand.

Synthesis, Experimental and Computational Evaluation of SERAAK1 as a 5-HT2A Receptor Ligand.

Journal: Molecules (Basel, Switzerland)

Published: March 26, 2025

Compound Heterozygous MRPS14 Variants Associated With Leigh Syndrome.

Compound Heterozygous MRPS14 Variants Associated With Leigh Syndrome.

Journal: Annals of clinical and translational neurology

Published: June 04, 2024

2-Aryladenine Derivatives as a Potent Scaffold for Adenosine Receptor Antagonists: The 6-Morpholino Derivatives.

2-Aryladenine Derivatives as a Potent Scaffold for Adenosine Receptor Antagonists: The 6-Morpholino Derivatives.

Journal: Molecules (Basel, Switzerland)

Published: February 08, 2024

Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening.

Discovery and in vitro Evaluation of Novel Serotonin 5-HT2A Receptor Ligands Identified Through Virtual Screening.

Journal: ChemMedChem

Published: January 26, 2024

Organ-Chips Enhance the Maturation of Human iPSC-Derived Dopamine Neurons.

Organ-Chips Enhance the Maturation of Human iPSC-Derived Dopamine Neurons.

Journal: International journal of molecular sciences

Published: August 01, 2023

Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds-synthesis, biological activity, and structural evaluation.

Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds-synthesis, biological activity, and structural evaluation.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: May 15, 2023

Development and Characterization of Novel Selective, Non-Basic Dopamine D2 Receptor Antagonists for the Treatment of Schizophrenia.

Development and Characterization of Novel Selective, Non-Basic Dopamine D2 Receptor Antagonists for the Treatment of Schizophrenia.

Journal: Molecules (Basel, Switzerland)

Published: April 30, 2023

Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents - Design, synthesis, structural studies and pharmacological profiling.

Discovery of novel arylpiperazine-based DA/5-HT modulators as potential antipsychotic agents - Design, synthesis, structural studies and pharmacological profiling.

Journal: European journal of medicinal chemistry

Published: December 23, 2022

Multitarget Derivatives of D2AAK1 as Potential Antipsychotics: The Effect of Substitution in the Indole Moiety.

Multitarget Derivatives of D2AAK1 as Potential Antipsychotics: The Effect of Substitution in the Indole Moiety.

Journal: ChemMedChem

Published: April 29, 2022

Design and Synthesis of Arylpiperazine Serotonergic/Dopaminergic Ligands with Neuroprotective Properties.

Design and Synthesis of Arylpiperazine Serotonergic/Dopaminergic Ligands with Neuroprotective Properties.

Journal: Molecules (Basel, Switzerland)

Published: December 15, 2021

Showing 1-12 of 33

Last Updated: 09/26/2026